Zachary Stassen - ViewRay Chief Officer

VRAYDelisted Stock  USD 0.04  0  5.67%   

Insider

Zachary Stassen is Chief Officer of ViewRay
Age 44
Phone440 703 3210
Webhttps://www.viewray.com

ViewRay Management Efficiency

The company has return on total asset (ROA) of (0.2529) % which means that it has lost $0.2529 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0891) %, meaning that it created substantial loss on money invested by shareholders. ViewRay's management efficiency ratios could be used to measure how well ViewRay manages its routine affairs as well as how well it operates its assets and liabilities.
ViewRay currently holds 86.4 M in liabilities with Debt to Equity (D/E) ratio of 0.54, which is about average as compared to similar companies. ViewRay has a current ratio of 2.98, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ViewRay's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Heather BrennanEstablishment Labs Holdings
N/A
Paul BadawiSight Sciences
49
Julie GannonVivos Therapeutics
N/A
Kristin CaltriderInogen Inc
56
Mojirade JamesAvanos Medical
57
Bradley JDAxogen Inc
54
Daniel BevevinoArtivion
61
Danielle WatsonHeart Test Laboratories
42
Jean HollowayArtivion
63
Mark SaxtonNeuropace
59
Chi NguyenNeuropace
47
S MansbachAvanos Medical
N/A
Andrew GreenArtivion
52
Jennifer ErnstTivic Health Systems
56
Salvador DadaEstablishment Labs Holdings
42
John DavisArtivion
59
David MDSight Sciences
54
Paul RodioEstablishment Labs Holdings
58
Scott CappsArtivion
53
James BullockArtivion
64
Amy HortonArtivion
50
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio. Viewray operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 267 people. ViewRay (VRAY) is traded on NASDAQ Exchange in USA and employs 295 people.

Management Performance

ViewRay Leadership Team

Elected by the shareholders, the ViewRay's board of directors comprises two types of representatives: ViewRay inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ViewRay. The board's role is to monitor ViewRay's management team and ensure that shareholders' interests are well served. ViewRay's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ViewRay's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert McCormack, Chief Officer
Robert Fuchs, Chief Officer
Zachary Stassen, Chief Officer
James Dempsey, Chief Scientific Officer, Director
Martin MD, Chief Officer
JD Ziegler, Chief Officer
Karen Hackstaff, VP Marketing
Scott Drake, CEO Pres
Matt Harrison, Director Relations
Drew Hill, VP Devel

ViewRay Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ViewRay a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Consideration for investing in ViewRay Stock

If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities